Antigen processing and presentation of exogenous peptide antigen

pathway activity — cross-omics
GO:0002478Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Antigen processing and presentation of exogenous peptide antigen pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PTPN22, CXCL9, and HLA-DQA1, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Antigen processing and presentation of exogenous peptide antigen activity versus PTPN22 in LSCC (Pearson r = 0.56).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCPTPN22 →+0.629+0.281<.001<.00139
BRCACXCL9 →+1.615+0.251.001<.00139
GBMHLA-DQA1 →+1.185+0.254<.001<.00139
BRCAIL12RB1 →+0.755+0.329<.001<.00139
HNSCTNFSF13B →+0.807+0.178<.001<.00138
BRCACD2 →+1.060+0.240.002<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002478 vs PTPN22 — LSCC

Per-sample scatter of Antigen processing and presentation of exogenous peptide antigen activity vs PTPN22 in LSCC.

Explore this scatter interactively →

Exploration